• 产品中心

    product
  • 产品目录
    Name
    Chemical Name
    Cas No.
    Final API Indication
    Scale Purity or Assay
    四氢异喹啉 1,2,3,4-Tetrahydroisoquinoline 91-21-4 MULTI NA Commercial ≥98.0%
    N-乙酰基-4-哌啶酮 N-Acetyl-4-piperidone 32161-06-1 MULTI NA Commercial ≥98.0%
    2,6-二溴吡啶 2,6-Dibromopyridine 626-05-1 MULTI NA Commercial ≥98.0%
    5-苯氧基异苯并呋喃-1-(3H)-酮 5-phenoxyisobenzofuran-1(3H)-one 57830-14-5 MULTI NA Commercial ≥99.0%
    (S)-2-(BOC-氨基)-3-[(S)-2-氧代-3-吡咯烷基]丙酸甲酯 Methyl (S)-2-(Boc-amino)-3-[(S)-2-oxo-3-pyrrolidinyl]propanoate 328086-60-8 PF-07321332帕罗韦德 NA Commercial ≥99.0%
    溴乙腈 Bromoacetonitrile 590-17-0 PF-07321332帕罗韦德 NA Commercial ≥99.0%
    (S)-4-苄基-2-唑烷酮 (S)-4-Benzyl-2-oxazolidinone 90719-32-7 Aliskiren阿利克伦 NA Commercial ≥99.0%
    2-乙基丁醇 2-Ethyl-1-butanol 97-95-0 Remdesivir瑞德西韦 NA Commercial ≥99.5%
    (S)-3-氰基-5-甲基己酸乙酯 (S)-3-Cyano-5-methyl-hexanoic acid ethyl ester 181289-39-4 Pregabalin普瑞巴林 NA Lab completed ≥97.0%
    2-[[(3aR,4S,6R,6aS)-6-氨基四氢-2,2-二甲基-4H-环戊并-1,3-二恶茂-4-基]氧基]-乙醇 (2R,3R)-2,3-二羟基丁二酸盐 2-{[(3aR,4S,6R,6aS)-6-amino-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl]oxy}ethanol 376608-65-0 Ticagrelor替格瑞洛 NA Commercial ≥99.0%
    (1R,2S)-2-(3,4-二氟苯基)环丙胺 (R)-扁桃酸盐 (1R,2R)-2-(3,4-difluorophenyl) cyclopropanamine(S)-(carboxylato(phenyl) methyl)holmium 376608-71-8 Ticagrelor替格瑞洛 NA Commerical ≥99.0%
    4-氯吡咯并嘧啶 4-Chloropyrrolo[2,3-d]pyrimidine 3680-69-1 Tofacitinib托法替尼 & Ruxolitinib芦可替尼 & Baricitinib巴瑞替尼 & Abrocitinib阿布昔替尼 & Oclacitinib奥拉替尼 NA Commercial ≥99.0%
    3-(4-甲基-1H-咪唑-1-基)-5-(三氟甲基)苯胺 3-(4-Methyl-imidazol-1-yl)-5-trifluoro-methylphenylamine 641571-11-1 Nilotinib 尼罗替尼 NA Commercial ≥98.0%
    二苯并[b,f][1,4]硫氮杂卓-11-[10H]酮 10H-Dibenzo[b,f][1,4]thiazepin-11-one 3159-07-7 Quetiapine喹硫平 NA Commercial ≥99.0%
    3-(甲氧基苯氧基)-1,2-环氧氯丙烷 1, 2-epoxy-3-(2-methoxyphenoxy)propane 2210-74-4 Ranolazine雷诺嗪 NA Commercial ≥97.5%
    章胺盐酸盐 Octopamine HCl 770-05-8 Ractopamine莱克多巴胺 NA Commercial ≥98.0%
    覆盆子酮 Raspberry ketone; 4-(4-hydroxyphenyl)-2-butanone 5471-51-2 Ractopamine莱克多巴胺 NA Commercial ≥98.0%
    对甲基苯磺酰甲基异腈 Tosylmethyl isocyanide 36635-61-7 MULTI NA Commercial ≥99.0%
    2,8-双(三氟甲基)-4-羟基喹啉 2,8-bis(trifluoromethyl)quinolin-4-ol 35853-41-9 Mefloquine氟甲喹羟哌啶 NA Commercial ≥97.0%
    N-叔丁基-十氢异喹啉-3(S)-甲酰胺 (S)-N-t-butyl decahydro-3-iso-quinolinecarboxamide 136465-81-1 Nelfinavir甲磺酸萘非那韦 & Saquinavir沙奎那韦 NA Commercial ≥98.0%
    (S)-2-苄基-N,N-二甲基氮杂环丙烷基-1-磺酰胺 (S)-2-Benzyl-N,N-dimethylaziridine-1-sulfonamide 902146-43-4 Cobicistat考西司他 NA Commercial ≥ 98.0%
    N-甲基-2-异丙基-4-噻唑甲胺二盐酸盐 1-(2-isopropylthiazol-4-yl)-N-methylmethanamine dihydrochloride 1185167-55-8 Cobicistat考西司他 NA Commercial ≥ 98.5%
    N-[N-甲基-N-(((2-异丙基-4-噻唑基)甲基)氨基羰基]-L-缬氨酸锂盐 N-[N-Methyl-N-((2-isopropyl-4-thiazolyl)methyl)aminocarbonyl]-L-valine lithium salt 201409-23-6 Ritonavir利托那韦 NA Commercial ≥ 97.0%
    ((5-噻唑基)甲基)-(4-硝基苯基)碳酸酯 Carbonic acid 4-nitrophenyl 5-thiazolylmethyl ester 144163-97-3 Ritonavir利托那韦 NA Commercial ≥98.0%
    3,5-二羟基戊苯 3,5-hydroxypentylbenzene 500-66-3 CBD大麻二酚 NA Commercial ≥99.0%
    1,3,5-三溴苯 1,3,5-Tribromobenzene 626-39-1 Buflomedil丁咯地尔 NA Commercial ≥99.0%
    原甲酸三丙酯 Tri-n-propyl orthoformate 621-76-1 MULTI NA Commercial ≥98.0%
    顺-4-苯硫基-L-脯氨酸 cis-4-Phenylthio-L-proline 81653-77-2 Fosinopril福辛普利 NA Commercial ≥98.0%
    2-氯-1-(3,4-二氟苯基)乙酮 2-Chloro-1-(3,4-difluoro-phenyl)-ethanone 51336-95-9 Ticagrelor替卡格雷 NA Commercial ≥99.0%
    沙格列汀 Saxagliptin 945667-22-1 361440-67-7 709031-45-8 CFDA USFDA Ⅱ型糖尿病 98.0%~102.0%
    3-邻苯二甲酰亚胺丙醛 3-Phthalimidopropionaldehyde 2436-29-5 Atorvastatin阿托伐他汀 NA Commercial ≥99.0%
    苄索氯铵 Benzethonium chloride 121-54-0 季铵盐类抗菌剂 Commercial ≥99.0%
    枸橼酸托法替布 Tofacitinib Citrate 540737-29-9 3680-69-1 479633-63-1 Lab completed JAK通路抑制剂;类风湿性关节炎 98.0%~102.0%
    恩曲他滨 Emtricitabine 143491-57-0 147126-75-8 2022-85-7 147126-62-3 USFDA WHO HIV-1、乙肝 ≥98.5%
    4-[2-(Boc-氨基)乙基]苯胺 [2-(4-Aminoa-phenyl)-ethyl]-carbamic acid tert-butyl ester 94838-59-2 Mirabegron米拉贝隆 NA Commercial ≥98.0%
    他扎罗汀 Tazarotene 118292-40-3 NA CFDA 用于治疗银屑病、痤疮,并用于角化异常性疾病、毛囊皮脂腺疾病、皮肤癌前期病变 98.5%~101.5%
    (1S,3S,5S)-3-(氨基羰基)-2-氮杂双环[3.1.0]己烷-2-甲酸 (1S,3S,5S)-3-(Aminocarbonyl)-2-azabicyclo[3.1.0]hexane-2-carboxylic acid tert-butyl ester 361440-67-7 Saxagliptin沙格列汀 NA Commercial Purity≥ 99.0%
    替格瑞洛 Ticagrelor 274693-27-5 51336-95-9 376608-71-8 376608-65-0 Lab completed 用于急性冠脉综合征 ≥99.0%
    (8-[2-羟基苯甲酰基]-氨基)辛酸钠 Salcaprozate Sodium 203787-91-1 NA Developing 口服吸收促进剂 ≥99%
    4-氯-7-甲苯磺酰基-7H-吡咯[2,3-D]嘧啶 4-Chloro-7-[(4-methylphenyl)sulfonyl]-7H-pyrrolo[2,3-d]pyrimidine 479633-63-1 Tofacitinib 托法替尼 NA Commercial ≥99.0%
    雷诺嗪 Ranolazine 95635-55-5 2210-74-4; 1131-01-7; 5294-61-1; Developing 治疗慢性心绞痛药 ≥99%
    甲磺酸达比加群酯 Dabigatran Etexilate Mesylate; Pradaxa 872728-81-9 212322-56-0 Lab completed 抗凝血药物 98.0%~102.0%
    2-氰基-2-甲基丙酸甲酯 2,2-Dimethylcyanoacetate methyl ester 72291-30-6 Multipurposes NA Commercial Purity≥98.0%
    (1S,3S,5S)-2-氮杂双环[3.1.0]己烷-3-甲酰胺甲烷磺酸盐 2-Azabicyclo[3.1.0]hexane-3-carboxaMide, (1S,3S,5S)-,MonoMethanesulfonate 709031-45-8 沙格列汀 NA Commercial Purity≥ 99.0%
    (S)-2-(Boc-氨基)-3-[(S)-2-氧代-3-吡咯烷基]丙酸甲酯 Methyl (S)-2-(Boc-amino)-3-[(S)-2-oxo-3-pyrrolidinyl]propanoate 328086-60-8 PF-07321332 NA Commercial Purity≥99.0%
    5-乙氧基-4-甲基唑 5-Ethoxy-4-methyloxazole 5006-20-2 VB6 NA Commercial Purity≥98.5%
    N-(2,6-二甲基苯基)-1-哌嗪乙酰胺 N-(2,6-Diphenylmethyl)-1-piperazine acetylamine 5294-61-1 雷诺嗪 NA Commercial Assay:98.0~102.0%
    2,6-二甲基氯代乙酰苯胺 2-Chloro-N-(2,6-dimethylphenyl)acetamide 1131-01-7 雷诺嗪 NA Commercial Assay: 97.0%~102.0%
    (1R,2S)-2-(3,4-二氟苯基)环丙胺盐酸盐 (1R,2S)-2-(3,4-difluorophenyl)cyclopropanamine hydrochloride 1402222-66-5 Ticagrelor替格瑞洛 NA Commercial Purity≥99%
    2,4-二氯-5-氟嘧啶 2,4-Dichloro-5-fluoropyrimidine 2927-71-1 Florasulam双氟磺草胺 NA Commercial ≥99.0%
    上一页1下一页 转至第